企查查數據:我國裝配式建築相關企業共1.35萬家,2020年新增3301家
格隆匯3月18日丨住建部近日發佈消息,2020年全國新開工裝配式建築共計6.3億㎡,較2019年增長50%,完成了《“十三五”裝配式建築行動方案》確定的工作目標。隨着政策驅動和市場內生動力的增強,近年來裝配式建築相關產業發展迅速。企查查數據顯示,目前我國共有1.35萬家裝配式建築相關企業,湖南省以2032家企業高居第一,山東、江蘇緊隨其後,長沙、深圳、合肥則是排名前三的城市。2016年以來,相關企業年註冊量大幅上升,2020年全年新註冊企業3301家,今年前2月新註冊326家,同比增長5%。


Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.